Durch organspezifische Präparate ermöglichen wir Ihnen den Schritt in die Zukunft der patientenindividuellen Krebsdiagnose und optimierter Krebs Therapie. Die Formulierung der von uns angebotenen Kits machen die Synthese zum verwendungsfertigen Produkte einfach und schnell.
Nuklearmedizin
Neue Alternativen zur Optimierung der Therapie von Krebs
Lutetium 177 (Lu-177) chlorid
n.c.a (Trägerfrei) | Gefässform wählbar | wöchentliche Erhältlichkeit
Isotopia Molecular Imaging Ltd. (“Isotopia”) is a unique nuclear pharmacy established in Israel since 2006, and has become an essential supplier for the growing field of nuclear medicine in Israel.
Isotopia, founded by a highly trained group of senior professionals, experienced in all aspects of radiopharmacy operations, in collaboration with a group of Canadian investors.
Nowadays, Isotopia is taking steps for becoming a major worldwide supplier of Lu-177 to be used in the field of molecular radiotherapy.
Our aim is to supply Lu -177 according to costumers needs. By producing Lu-177 C.A and Lu-177 N.C.A, we can provide you both products according to your needs, tailor-made.
Die wichtigsten Vorteile:
- Continuous supply of Lu-177 C.A guaranteed due to cooperation with
various nuclear reactors. - Availability- on a weekly basis all year round
- You choose your volume (fixed concentration)
- V Shaped for minimum material loss .
- Each lot is tested for labeling efficiency
Ordering Process
3 simple Steps: just define
Get Lu 177 according to your needs
Product Specifications
3 simple Steps: just define
| Radionuclide | 177LU Lutetium Chloride Solution |
| Half -life | 6.65 days |
| Decay Mode | Beta decay |
| Chemical form | LuCl3 in 0.04 HCI |
| Test | c.a. | n.c.a |
|---|---|---|
| Appearance | Clear, colorless solution | Clear, colorless solution |
| pH | 1.0 — 2.0 | 1.0 — 2.0 |
| Identification | Gamma photons with 208 KeV and 113 KeV present | Gamma photons with 208 KeV and 113 KeV present |
| Specific Activity (by ICP-OES at end of production) | >740 GBq/mg (>20 Ci/mg) | >3,000 GBq/mg |
| Chemical Purity (by ICP-OES) | Cu ≤ 1.0 μg/GBq Fe ≤ 0.5 μg/GBq Pb ≤ 0.5 μg/GBq Zn ≤ 1.0 μg/GBq | Cu ≤1.0 μg/GBq Fe ≤0.5 μg/GBq Pb ≤0.5 μg/GBq Zn ≤1.0 μg/GBq 176Yb≤1.0 μg/GBq |
| Radionuclidic Purity (Gamma spectrometry) | 177mLu <0.07% | 175Yb < 0.1% |
| The total radioactivity due to other radionuclidic impurities < 0.01% | The total radioactivity due to other radionuclidic impurities < 0.01% |
|
| Radiochemical Purity (by iTLC) | [177Lu]lutetium(III) ion > 99% | [177Lu]lutetium(III) ion > 99% |
| Bacterial Endotoxins | 35 < EU/ml | 35 < EU/ml |
| Sterility | Retrospectively tested after decay |